Supplementary Figure 3

1
Supplementary Figure Supplementary Figure 3 Involvement of the oxidative stress in the response of iPrEC cells to Doxo and DTX treatments. Flow cytometric evaluation of (a) ROS generation and (b) apoptosis, carried out in the drug-exposed iPrEC cells, previously loaded with NAC agent. (c) Analysis of ROS production performed in Doxo- and DTX-treated iPrEC transfectants. % ROS a iPrEC - + - + - + NAC Doxo (0,75 µM) DTX (10 nM) Untreated % Apoptosis (Ann V+/PI- cells) - + - + - + NAC Doxo (0,75 µM) DTX (10 nM) Untreated b iPrEC c USP2a WT USP2a MUT EV ROS generation Untreated Doxo (0,75 µM) Untreated DTX (10 nM)

description

Supplementary Figure 3. a. iPrEC. Untreated. Untreated. Doxo (0,75 µM). DTX (10 nM). % ROS. % Apoptosis (Ann V+/PI- cells). b. iPrEC. -. -. -. -. -. -. +. +. +. +. +. +. c. NAC. NAC. EV. USP2a MUT. USP2a WT. Untreated. Untreated. Doxo (0,75 µM). Doxo - PowerPoint PPT Presentation

Transcript of Supplementary Figure 3

Page 1: Supplementary Figure 3

Supplementary Figure 3

Supplementary Figure 3 Involvement of the oxidative stress in the response of iPrEC cells to Doxo and DTX treatments.

Flow cytometric evaluation of (a) ROS generation and (b) apoptosis, carried out in the drug-exposed iPrEC cells, previously loaded with NAC agent. (c) Analysis of ROS production performed in Doxo- and DTX-treated iPrEC transfectants.

% R

OS

aiPrEC

- + - + - + NAC

Doxo(0,75 µM)

DTX(10 nM)

Untreated

% A

popt

osis

(A

nn V

+/P

I- c

ells

)

- + - + - + NAC

Doxo(0,75 µM)

DTX(10 nM)

Untreated

biPrEC

c USP2aWTUSP2aMUTEV

ROS generation

Untreated Doxo (0,75 µM)

Untreated DTX (10 nM)